The route of administration of most drugs, including antibiotics, is often decided empirically based on bioavailability data from animal studies. Increasing knowledge, however, of the transport mechanisms participating in solute uptake from the human intestine has improved our understanding of the absorption of peptide drugs (including a number of antibiotics). This article will briefly discuss dipeptide transport in humans and then focus on the intestinal absorption ofpeptide drugs, in particular f-lactam antibiotics, and the therapeutic implications ofresearch in this field. f-lactam compounds are weakly acidic peptides and thus expected to be poorly absorbed from the gastrointestinal tract. Some ofthe drugs in this group, however, have surprisingly good oral bioavailability because of the utilisation of carrier mediated transport systems for small peptides within the brush border. Peptide compounds, particularly hormones and their analogues, are increasingly used therapeutically, although oral bioavailability is often a problem. Specific pharmacological design to facilitate intestinal absorption is potentially of great benefit. Design ofdrugs specifically to exploit carrier systems is important as the clinical usefulness of a compound is greatly enhanced if it is well absorbed when given by mouth.
Mammalian peptide transport systems
To reach the bloodstream from the gut lumen, solutes must either first cross the brush border membrane of the enterocyte microvilli, traverse the enterocyte cytoplasm, and exit by the basolateral membrane or enter by the paracellular route. Protein is predominantly absorbed from the mammalian gut as amino acids and oligopeptides, although some larger peptides may also be absorbed intact.' Absorption of these molecules entails both passive diffusion through the paracellular pathways, and facilitated by carrier mediated transport. It is the use of these carrier mediated Figure 2 illustrates the structural similarities between dipeptides and B-lactam antibiotics. Paracellular
It is assumed that once across the brush border membrane pathway fB-lactams diffuse freely through the enterocyte cytoplasm.
The mechanism by which they leave the enterocyte is ross the unknown. An outwardly directed proton symport for gylcylproline, however, has recently been shown in the basolateral membrane from rabbit small intestine. 43 There is a potential alternative but probably non-selective route across the intestinal epithelium, the so called paracellular pathway through the tight junction between enterocytes (Fig 2) . Whether 
